Special issue on illicit drugs

Drug Testing and Analysis

Volumn 3, Issue 9, 2011, Pages 525-526

  Brandt, Simon D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ILLICIT DRUG;

CANNABINOID DERIVATIVE; CATHINONE; COCAINE; ILLICIT DRUG; PSILOCYBINE; RECREATIONAL DRUG; TETRAHYDROCANNABINOL; TRYPTAMINE;

CATHA EDULIS; CHEMICAL ANALYSIS; CHEMICAL COMPOSITION; DRUG SCREENING; DRUG SURVEILLANCE PROGRAM; EDITORIAL; FORENSIC SCIENCE; INTERNET; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAMAN SPECTROMETRY; SEXUAL CRIME;

EID: 80053387074     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.308     Document Type: Editorial

References (16)

1. J. Kerwin, Doors of deception -The diaspora of designer drugs. Drug Test. Analysis 2011, 3, 527.
2. M. J. West, M. J. Went Detection of drugs of abuse by Raman spectroscopy. Drug Test. Analysis 2011, 3, 532.
3. A. D. Burnett, H. G. M. Edwards, M. D. Hargreaves, T. Munshi, K. Page A forensic case study: the detection of contraband drugs in carrier solutions by Raman spectroscopy. Drug Test. Analysis 2011, 3, 539.
4. 1H magnetic resonance spectroscopy. Drug Test. Analysis 2011, 3, 544.
5. R. A. Aleryani, S. L. Aleryani, A. A. Al-Akwac Khat a drug of abuse: roles of free radicals and antioxidants. Drug Test. Analysis 2011, 3, 548.
6. L. Karila, M. Reynauda GHB and synthetic cathinones: clinical effects and potential consequences. Drug Test. Analysis 2011, 3, 552.
7. H. Andresen, B. E. Aydin, A. Mueller, S. Iwersen-Bergmann Gamma hydroxybutyric acid: an overview. Pharmacodynamics, pharmacokinetics, toxic effects, addiction, analytical methods, interpretation of results. Drug Test. Analysis 2011, 3, 560.
8. S. D. Brandt, S. Freeman, H. R. Sumnall, F. Measham, J. Cole Analysis of NRG 'legal highs' in the UK: Identification and formation of novel cathinones. Drug Test. Analysis 2011, 3, 569.
9. M. Baron, M. Elie, L. Elie Analysis of legal highs-do they contain what it says on the tin? Drug Test. Analysis 2011, 3, 576.
10. J. C. Lin, R. K. Jan, R. R. Kydd, B. R. Russell Subjective effects of party pill drugs BZP and TFMPP alone and in combination in humans. Drug Test. Analysis 2011, 3, 582.
11. L. P. Carter Potential impact of drug effects, availability, pharmacokinetics, and screening on estimates of drugs implicated in cases of assault. Drug Test. Analysis 2011, 3, 586.
12. T. Shoda, K. Fukuhara, Y. Goda, H. Okuda Enzyme-assisted synthesis of the glucuronide conjugate of psilocin, an hallucinogenic component of magic mushrooms. Drug Test. Analysis 2011, 3, 594.
13. 4]-tryptamines. Drug Test. Analysis 2011, 3, 597.
14. I. Möller, A. Wintermeyer, K. Bender, M. Jübner, A. Thomas, O. Krug, W. Schänzer, M. Thevis Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls. Drug Test. Analysis 2011, 3, 609.
15. T.M. Brunt, R.J.M. Niesink The Drug Information and Monitoring System (DIMS) in the Netherlands: Implementation, results, and international comparison. Drug Test. Analysis 2011, 3, 621.
16. M. Dunn, R. Bruno, L. Burns & A. Roxburgh Effectiveness of and challenges faced by surveillance systems. Drug Test. Analysis 2011, 3, 635.